The Coalition for Epidemic Preparedness Innovations (CEPI) and the University of Oxford have entered into a strategic partnership to accelerate the development of globally accessible vaccines against endemic outbreaks.
https://european-biotechnology.com/wp-content/uploads/2024/04/CEPI_Oxford.jpeg12062318Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-08-30 08:46:382024-07-09 14:27:02CEPI commits up to US$80m to University of Oxford to develop vaccines